Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia
Experimental Hematology · 2024
DOI: 10.1016/j.exphem.2024.104206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Hematology, 2024. Verfasst von Qiaoxue Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Erythrocyte Indices. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: CAMS Innovation Fund for Medical Sciences, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Many prognostic factors have been identified in acute myeloid leukemia (AML). In this study, we investigated novel prognostic biomarkers using machine learning and Cox regression models in a prospective cohort of 591 patients with AML and tried to identify potential therapeutic targets based on transcriptomic data. We found that elevated red blood cell distribution width (RDW) at diagnosis was an adverse prognostic factor for AML, independent of the 2022 European LeukemiaNet (ELN2022) genetic risk. As a continuous variable, higher RDW was associated with shorter overall survival (OS) (hazard ratio [HR] 1.087, 95% confidence interval [CI] 1.036-1.139, p < 0.001) and event-free survival (EFS) (HR 1.078, 95% CI 1.033-1.124, p < 0.001). Elevated RDW returned to normal after consolidation therapy, which indicated that leukemia cells resulted in abnormal RDW. We further investigated the relationship between RDW and transcriptome in another cohort of 191 patients with AML and public datasets using gene set enrichment analysis (GSEA) and cell-type identification by estimating relative subsets of RNA transcripts (CIBERSORT). We found that patients in the high-RDW group were significantly enriched in the positive regulation of erythroid differentiation and inflammation-related pathways. Finally, we identified the inflammation-associated gene IL12RB2 and verified its prognostic relevance with patients with AML in public databases, suggesting it as a potential therapy target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
Förderung
- CAMS Innovation Fund for Medical Sciences
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Tianjin Municipal Science and Technology Committee
- Chinese Academy of Meteorological Sciences
Zitieren
APA
Liu, Q., Zhai, Y., Hui, Y., Chen, J., Mi, Y., Wang, J., & Wei, H. (2024). Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia. Experimental Hematology. https://doi.org/10.1016/j.exphem.2024.104206
Vancouver
Liu Q, Zhai Y, Hui Y, Chen J, Mi Y, Wang J, et al. Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia. Experimental Hematology. 2024. doi:10.1016/j.exphem.2024.104206
BibTeX
@article{Liu2024,
author = {Liu, Qiaoxue and Zhai, Yujia and Hui, Yan and Chen, Jiayuan and Mi, Yingchang and Wang, Jianxiang and Wei, Hui},
title = {Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia},
journal = {Experimental Hematology},
year = {2024},
doi = {10.1016/j.exphem.2024.104206}
}
EUVIMED